All NEW Investors: Your gift matched $ for $ this week! GIVE NOW

Cancer drugs are big money for big pharma

Dan Gorenstein Aug 26, 2013
HTML EMBED:
COPY

Cancer drugs are big money for big pharma

Dan Gorenstein Aug 26, 2013
HTML EMBED:
COPY
The hot tip in pharmaceuticals: cancer drugs.
 
This morning, drug maker AstraZeneca scooped up a biotech company for its treatments to help the immune system fight cancer.
 
Yesterday, Amgen bought out a firm with a cancer drug that could generate $1 billion dollars in sales by 2015.
 
Imagine for a moment that you are a small biotech firm, and you manufacture drugs to treat cancer. University of Michigan’s Erik Gordon says pharmaceutical giants may soon be knocking.
 
“What’s going on now is there have been so many product failures at big companies where the drugs they are trying to develop themselves haven’t panned out, that they end up going for whoever has a drug that looks pretty good,” says Gordon.
 
According to the firm EvaluatePharma, cancer drugs made up $84 billion in global sales last year, only trailing treatments to the central nervous system.
 
Bloomberg Industries Andrew Berens says cancer drugs are so hot because many primary care diseases, like high blood pressure, have gone generic. And, Berens says companies can charge a premium for cancer treatments.
 
“It’s not a chronic therapy. It’s a life-threatening disease… for a very definitive period of time. So you don’t see payers really pushing back on those types of diseases,” he says.
Berens says that since prices can run $10,000 or more a month, he expects big pharma to snap up as many cancer drugs as it can.

 

We’re here to help you navigate this changed world and economy.

Our mission at Marketplace is to raise the economic intelligence of the country. It’s a tough task, but it’s never been more important.

In the past year, we’ve seen record unemployment, stimulus bills, and reddit users influencing the stock market. Marketplace helps you understand it all, will fact-based, approachable, and unbiased reporting.

Generous support from listeners and readers is what powers our nonprofit news—and your donation today will help provide this essential service. For just $5/month, you can sustain independent journalism that keeps you and thousands of others informed.